Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan
· Delayed Price · Currency is TWD 38.15
-0.50 (-1.29%)
Jun 13, 2025, 1:25 PM CST
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| Factory Operations | 847.11M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Factory Operations Growth | 89.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global Business | 39.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global Business Growth | -38.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Affairs | 3.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Affairs Growth | 50.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| Taiwan | 679.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | 167.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 178.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -17.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Philippines | 23.81M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 18.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -99.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 7.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 99.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China and Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China and Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|